SAVA - CASSAVA SCIENCES INC

QQQ $ 608.00 $ -9.68 (-1.57 %)

DIA $ 474.65 $ -6.71 (-1.39 %)

SPY $ 671.58 $ -8.89 (-1.31 %)

TLT $ 89.43 $ -0.38 (-0.42 %)

GLD $ 382.91 $ -4.36 (-1.13 %)

Previous Close

$ 3.26

Open

$ 3.13

Bid

$ 2.90 x 2,285

Ask

$ 2.91 x 957

Day's Range

$ 2.90 - $ 3.20

52 Week Range

$ 1.15 - $ 33.98

Volume

1,762,956

Average Volume

Market Cap

157.48M

Beta (5Y Monthly)

$ 1.36

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-12-2025	09-30-2025	10-Q
2	08-14-2025	06-30-2025	10-Q
3	05-08-2025	03-31-2025	10-Q
4	03-03-2025	01-01-1970	10-K
5	11-07-2024	09-30-2024	10-Q
6	08-08-2024	06-30-2024	10-Q
7	05-10-2024	03-31-2024	10-Q
8	02-28-2024	12-31-2023	10-K
9	11-07-2023	09-30-2023	10-Q
10	08-03-2023	06-30-2023	10-Q
11	05-01-2023	03-31-2023	10-Q
12	02-28-2023	12-31-2022	10-K
13	11-07-2022	09-30-2022	10-Q
14	08-04-2022	06-30-2022	10-Q
15	05-05-2022	03-31-2022	10-Q
16	02-28-2022	12-31-2021	10-K
17	11-15-2021	09-30-2021	10-Q
18	08-04-2021	06-30-2021	10-Q
19	04-29-2021	03-31-2021	10-Q
20	03-23-2021	12-31-2020	10-K
21	11-09-2020	09-30-2020	10-Q
22	08-12-2020	06-30-2020	10-Q
23	05-06-2020	03-31-2020	10-Q
24	03-26-2020	12-31-2019	10-K
25	10-29-2019	09-30-2019	10-Q
26	08-12-2019	06-30-2019	10-Q
27	05-02-2019	03-31-2019	10-Q
28	03-29-2019	12-31-2018	10-K
29	10-30-2018	09-30-2018	10-Q
30	07-26-2018	06-30-2018	10-Q
31	05-09-2018	03-31-2018	10-Q
32	02-06-2018	12-31-2017	10-K
33	11-01-2017	09-30-2017	10-Q
34	08-09-2017	06-30-2017	10-Q
35	04-26-2017	03-31-2017	10-Q
36	03-07-2017	12-31-2016	10-K
37	10-26-2016	09-30-2016	10-Q
38	07-19-2016	06-30-2016	10-Q
39	05-05-2016	03-31-2016	10-Q
40	03-03-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cassava Sciences Q3 EPS $(0.22) Beats $(0....
11/12/2025 13:12:13

Cassava Sciences (NASDAQ:SAVA) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0....

Cassava Sciences Says U.S. Court Dismisses...
10/24/2025 12:14:23

- SEC Filing

LUCID CAPITAL MARKETS Initiates Coverage O...
10/06/2025 12:50:40

LUCID CAPITAL MARKETS analyst Elemer Piros initiates coverage on Cassava Sciences (NASDAQ:SAVA) with a Buy rating and announ...

12 Health Care Stocks Moving In Tuesday's ...
09/23/2025 17:06:52

cassava-sciences-sava-stock-is-surging-tuesday-whats-going-on

Cassava Sciences (SAVA) Stock Is Surging T...
09/23/2025 14:19:22

Cassava Sciences shares are trading higher Tuesday morning. A Form 4 filing disclosed that CEO Rick Barry acquired 237,941 shar...

12 Health Care Stocks Moving In Tuesday's ...
09/23/2025 12:09:16

why-super-league-enterprise-shares-are-trading-higher-by-200-here-are-20-stocks-moving-premarket

Why Super League Enterprise Shares Are Tra...
09/23/2025 09:41:19

12 Health Care Stocks Moving In Monday's A...
09/22/2025 21:06:10

Cassava Sciences Form4 Filing Shows CEO Ri...
09/22/2025 20:22:59

- SEC Filing

Cassava Sciences Q2 EPS $(0.92) Down From ...
08/14/2025 11:35:38

Cassava Sciences (NASDAQ:SAVA) reported quarterly losses of $(0.92) per share. This is a 807.69 percent decrease over earnings ...

Cassava Sciences Reports Preclinical Resul...
08/04/2025 11:33:04

The Tsc1-CKO mice were treated with several doses of simufilam. Seizure activity was monitored for approximately three weeks af...

Cassava Sciences Presented A Poster At The...
06/30/2025 11:02:08

The poster detailed two important observations that support Cassava's plan to initiate human clinical studies in H1 2026 to...

'FDA Clears First Blood Test Used In Diagn...
05/16/2025 17:32:57

https://www.fda.gov/news-events/press-announcements/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease#:~:text=The%...

Cassava Sciences Q1 EPS $(0.48) Down From ...
05/08/2025 12:14:14

Cassava Sciences (NASDAQ:SAVA) reported quarterly losses of $(0.48) per share. This is a 11.63 percent decrease over losses of ...

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
03/25/2025 17:05:55

HC Wainwright & Co. Reiterates Neutral on ...
03/25/2025 15:40:19

HC Wainwright & Co. analyst Vernon Bernardino reiterates Cassava Sciences (NASDAQ:SAVA) with a Neutral and maintains $2 ...

cassava-sciences-discontinues-developing-simufilam-for-alzheimers-after-another-phase-3-trial-flop

Cassava Sciences Discontinues Developing S...
03/25/2025 14:42:19

Cassava Sciences is ending simufilam development for Alzheimer's after Phase 3 trials failed. The company is shifting focus...

Cassava Sciences Reports Topline Phase 3 R...
03/25/2025 12:13:04

Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in pat...

HC Wainwright & Co. Reiterates Neutral on ...
03/04/2025 17:23:59

HC Wainwright & Co. analyst Vernon Bernardino reiterates Cassava Sciences (NASDAQ:SAVA) from Neutral to Neutral.

tesla-rebounds-while-tariffs-weigh-on-manufacturing-whats-driving-markets-monday

Tesla Rebounds While Tariffs Weigh On Manu...
03/03/2025 17:18:23

Stocks fell broadly on Monday to start the month of March with all three major indices red in midday trading. Investors digeste...

These Small Caps Are Betting Big On Americ...
10/19/2020 13:20:40